Response and adverse drug reactions to combination chemotherapy in elderly patients with aggressive non-Hodgkin's ymphoma: comparison of CHOP, COP-BLAM, COP-BLAM III, and THP-COPBLM
Author:
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1999.tb01137.x/fullpdf
Reference22 articles.
1. International non-Hodgkins lymphoma prognostic factors project: a predictive model for aggressive non-Hodgkins lymphoma;Shipp;N Engl J Med,1993
2. Prognostic factors in elderly patients with non-Hodgkins lymphoma treated with cyclophosphamide, vincristine, prednisolone, bleomycin, adriamycin and procarbazine (COP-BLAM) therapy;Niitsu;Acta Haematol,1997
3. Treatment of cancer in the elderly;Fentiman;Br J Cancer,1991
4. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma;Dixon;J Clin Oncol,1986
5. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkins lymphoma;Vose;J Clin Oncol,1988
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An evaluation based on relative treatment intensity in older patients treated with reduced-dose R-THP-COP therapy for diffuse large B-cell lymphoma: A multicenter retrospective cohort study;Journal of Geriatric Oncology;2023-01
2. Comparison of CHOP with THP-COP for peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective analysis using data from the population-based Osaka Cancer Registry;International Journal of Hematology;2021-04-16
3. Transarterial chemoembolization with pirarubicin-eluting microspheres in patients with unresectable hepatocellular carcinoma: Preliminary results;Journal of Interventional Medicine;2019-05
4. CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin;Hematological Oncology;2015-10-09
5. Improved treatment results of children with B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study;Pediatric Blood & Cancer;2014-02-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3